Sam Altman-backed AI biotech announces $1 billion for its lofty goal: adding 10 years to human life span
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
Sam Altman’s World now wants to link AI agents to your digital identity
OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...
eWeek5d
Sam Altman’s AI Briefing: Super-Agents To Revolutionize Software, Finance, and More
OpenAI CEO Sam Altman will brief U.S. officials on super-agents—AI systems set to revolutionize software development, finance ...
Sam Altman reportedly backs $1B round for AI healthcare startup Retro Biosciences
Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in ...
OpenAI launches Operator, an AI agent that performs tasks autonomously
OpenAI announced that it is launching a research preview of Operator, an AI agent that can take control of a browser and perform tasks.